Feature Paper in Biosensor and Bioelectronic Devices 2024

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensor and Bioelectronic Devices".

Deadline for manuscript submissions: closed (31 December 2024) | Viewed by 33178

Special Issue Editor


E-Mail Website
Guest Editor
Chemistry Department, University Paris Diderot, Sorbonne Paris Cité, ITODYS, UMR 7086 CNRS 15 rue J-A de Baïf, CEDEX 13, 75205 Paris, France
Interests: bioelectrochemistry; biosensors; bioelectronics; transistor; nanomaterials
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue, entitled “Feature Paper in Biosensor and Bioelectronic Devices 2024”, represents an expanding disciplinary field that combines biosensors with various emerging technologies. This Special Issue’s scope includes, but is not limited to, the design, development, and application of biosensors (enzyme sensors, immunosensors, DNA/RNA sensors, etc.) and bioelectronic devices (electronic nose, electronic tongue, implantable electronics, etc.) in the biological, medical, environmental and industrial fields, with an emphasis on matters of worldwide interest.

Prof. Dr. Benoît Piro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • micro electro mechanical systems (MEMS)
  • optical biosensors
  • nanotechnology in biosensors
  • flexible and wearable biosensors
  • portable biosensors

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (19 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

19 pages, 4762 KiB  
Article
Enzyme Biosensor Based on 3D-Printed Flow-Through Reactor Modified with Thiacalixarene-Functionalized Oligo (Lactic Acids)
by Dmitry Stoikov, Dominika Kappo, Alexey Ivanov, Vladimir Gorbachuk, Olga Mostovaya, Pavel Padnya, Ivan Stoikov and Gennady Evtugyn
Biosensors 2025, 15(2), 77; https://doi.org/10.3390/bios15020077 - 29 Jan 2025
Viewed by 879
Abstract
Electrochemical enzyme biosensors are extensively utilized in clinical analysis and environmental monitoring, yet achieving effective enzyme immobilization while maintaining high activity remains a challenge. In this work, we developed a flow-through enzyme biosensor system using a 3D-printed flow-through electrochemical cell fabricated from commercially [...] Read more.
Electrochemical enzyme biosensors are extensively utilized in clinical analysis and environmental monitoring, yet achieving effective enzyme immobilization while maintaining high activity remains a challenge. In this work, we developed a flow-through enzyme biosensor system using a 3D-printed flow-through electrochemical cell fabricated from commercially available poly (lactic acid). After modification with thiacalixarene-functionalized oligo (lactic acids) (OLAs), the material enabled efficient immobilization of uricase on the inner surface of a replaceable reactor of the cell. Swelling and hydrolytic stability of OLAs in cone, partial cone, and 1,3-alternate conformations were studied, with 1,3-alernate conformation demonstrating superior stability and enzyme immobilization performance. The use of OLAs enhanced immobilization efficiency by over 30% and protected the reactor from swelling, hydrolytic degradation, and enzyme loss. The biosensor was validated for amperometric uric acid determination, with a screen-printed carbon electrode modified with carbon black and Prussian Blue. This modification reduced the cathodic potential for uric acid detection to –0.05 V. The biosensor exhibited a linear detection range of 10 nM to 30 μM with a detection limit of 7 nM, and it performed effectively in artificial urine and synthetic blood plasma. The novel cell design, featuring easy assembly and low-cost replaceable parts, makes this biosensor a promising candidate for routine clinical analysis and other practical applications. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

11 pages, 3947 KiB  
Article
BSA-Assisted Synthesis of Au Nanoclusters/MnO2 Nanosheets for Fluorescence “Switch-On” Detection of Alkaline Phosphatase
by Yijiong Xue, Chengqi Bao, Hui Liu, Fanghui Ma, Minghui Yang and Xiaoqing Li
Biosensors 2025, 15(1), 49; https://doi.org/10.3390/bios15010049 - 15 Jan 2025
Cited by 1 | Viewed by 943
Abstract
A fluorescence probe for “switch-on” detection of alkaline phosphatase (ALP) was developed based on Au nanoclusters anchored MnO2 nanosheets (Au NCs-MnO2 NSs), which were synthesized using bovine serum albumin (BSA) as template through a simple one-pot approach. In the sensing system, [...] Read more.
A fluorescence probe for “switch-on” detection of alkaline phosphatase (ALP) was developed based on Au nanoclusters anchored MnO2 nanosheets (Au NCs-MnO2 NSs), which were synthesized using bovine serum albumin (BSA) as template through a simple one-pot approach. In the sensing system, MnO2 NSs function as both energy acceptors and target identifiers, effectively quenches the fluorescence of Au NCs via fluorescence resonance energy transfer (FRET). The presence of ALP catalyzes the hydrolysis of L-ascorbic acid-2-phosphate (AAP) to ascorbic acid (AA), reducing MnO2 NSs to Mn2+ and facilitate the fluorescence recovery of Au NCs. The fluorescence assay offers the advantages of facile preparation, cost-effectiveness, good specificity, and high sensitivity. Moreover, the assay exhibits a broad linear range (0.005 U/mL to 8 U/mL) for ALP detection with a remarkable limit of detection of 0.0015 U/mL. Notably, this assay demonstrates promising applicability for detection ALP in human serum samples, thereby providing valuable potential for clinical applications. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

17 pages, 2598 KiB  
Article
Anti-Tissue-Transglutaminase IgA Antibodies Presence Determination Using Electrochemical Square Wave Voltammetry and Modified Electrodes Based on Polypyrrole and Quantum Dots
by Angela Gabriela Pãun, Simona Popescu, Alisa Ioana Ungureanu, Roxana Trusca, Alina Popp, Cristina Dumitriu and George-Octavian Buica
Biosensors 2025, 15(1), 42; https://doi.org/10.3390/bios15010042 - 13 Jan 2025
Cited by 1 | Viewed by 963
Abstract
A novel electrochemical detection method utilizing a cost-effective hybrid-modified electrode has been established. A glassy carbon (GC) modified electrode was tested for its ability to measure electrochemical tTG antibody levels, which are essential for diagnosing and monitoring Celiac disease (CD). Tissue transglutaminase protein [...] Read more.
A novel electrochemical detection method utilizing a cost-effective hybrid-modified electrode has been established. A glassy carbon (GC) modified electrode was tested for its ability to measure electrochemical tTG antibody levels, which are essential for diagnosing and monitoring Celiac disease (CD). Tissue transglutaminase protein biomolecules are immobilized on a quantum dots-polypyrrole nanocomposite in the improved electrode. Initial, quantum dots (QDs) were obtained from Bombyx mori silk fibroin and embedded in polypyrrole film. Using carbodiimide coupling, a polyamidoamine (PAMAM) dendrimer was linked with GQDs-polypyrrole film to improve sensor sensitivity. The tissue transglutaminase (tTG) antigen was cross-linked onto PAMAM using N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC)-N-hydroxy succinimide (NHS) chemistry to develop a nanoprobe that can detect human serum anti-tTG antibodies. The physicochemical characteristics of the synthesized nanocomposite were examined by FTIR, UV-visible, FE-SEM, EDX, and electrochemical studies. The novel electrode measures anti-tissue antibody levels in real time using human blood serum samples. The modified electrode has great repeatability and an 8.7 U/mL detection limit. Serum samples from healthy people and CD patients were compared to standard ELISA kit assays. SPSS and Excel were used for statistical analysis. The improved electrode and detection system can identify anti-tissue antibodies up to 80 U/mL. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

17 pages, 2167 KiB  
Article
Stress Monitoring in Pandemic Screening: Insights from GSR Sensor and Machine Learning Analysis
by Antonios Georgas, Anna Panagiotakopoulou, Grigorios Bitsikas, Katerina Vlantoni, Angelo Ferraro and Evangelos Hristoforou
Biosensors 2025, 15(1), 14; https://doi.org/10.3390/bios15010014 - 2 Jan 2025
Viewed by 1759
Abstract
This study investigates the impact of patient stress on COVID-19 screening. An attempt was made to measure the level of anxiety of individuals undertaking rapid tests for SARS-CoV-2. To this end, a galvanic skin response (GSR) sensor that was connected to a microcontroller [...] Read more.
This study investigates the impact of patient stress on COVID-19 screening. An attempt was made to measure the level of anxiety of individuals undertaking rapid tests for SARS-CoV-2. To this end, a galvanic skin response (GSR) sensor that was connected to a microcontroller was used to record the individual stress levels. GSR data were collected from 51 individuals at SARS-CoV-2 testing sites. The recorded data were then compared with theoretical estimates to draw insights into stress patterns. Machine learning analysis was applied for the optimization of the sensor results. Classification algorithms allowed the automatic reading of the sensor results and individual identification as “stressed” or “not stressed”. The findings confirmed the initial hypothesis that there was a significant increase in stress levels during the rapid test. This observation is critical, as heightened anxiety may influence a patient’s willingness to participate in screening procedures, potentially reducing the effectiveness of public health screening strategies. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

12 pages, 2809 KiB  
Article
Microspectrometer-Enabled Real-Time Concentration Monitoring in the Microfluidic Protein Enrichment Chip
by Dong-Li Li, Wen-Shu Huang, Yi Hung Wu and Chun-Ping Jen
Biosensors 2025, 15(1), 1; https://doi.org/10.3390/bios15010001 - 24 Dec 2024
Cited by 1 | Viewed by 971
Abstract
This study presents a novel microspectrometer-integrated microfluidic system for real-time protein concentration monitoring. The device employs electrokinetic principles for efficient protein preconcentration in a PDMS and Nafion film channel. Using FITC-labeled BSA as a model protein, the system demonstrated a linear correlation between [...] Read more.
This study presents a novel microspectrometer-integrated microfluidic system for real-time protein concentration monitoring. The device employs electrokinetic principles for efficient protein preconcentration in a PDMS and Nafion film channel. Using FITC-labeled BSA as a model protein, the system demonstrated a linear correlation between protein concentration and absorbance at 491 nm. Notably, it achieved a 833-fold concentration increase from an initial 10 nM within 20 min. The compact microspectrometer system offers enhanced accuracy and sensitivity compared to traditional fluorescence microscopy methods. This innovation presents a promising solution for portable and point-of-care diagnostic applications, facilitating timely disease detection and monitoring. The findings highlight the potential for this technology to advance protein analysis and biomarker discovery in clinical settings, potentially improving patient outcomes through enhanced diagnostic capabilities. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

18 pages, 5794 KiB  
Article
Competitive Electrochemical Apta-Assay Based on cDNA–Ferrocene and MXenes for Staphylococcus aureus Surface Protein A Detection
by Ana-Maria Tătaru, Alexandra Canciu, Alin-Dan Chiorean, Ioana Runcan, Alexandru Radu, Mădălina Adriana Bordea, Maria Suciu, Mihaela Tertiș, Andreea Cernat and Cecilia Cristea
Biosensors 2024, 14(12), 636; https://doi.org/10.3390/bios14120636 - 21 Dec 2024
Viewed by 1109
Abstract
Staphylococcus aureus (S. aureus) represents one of the most frequent worldwide causes of morbidity and mortality due to an infectious agent. It is a part of the infamous ESKAPE group, which is highly connected with increased rates of healthcare-associated infections and [...] Read more.
Staphylococcus aureus (S. aureus) represents one of the most frequent worldwide causes of morbidity and mortality due to an infectious agent. It is a part of the infamous ESKAPE group, which is highly connected with increased rates of healthcare-associated infections and antimicrobial resistance. S. aureus can cause a large variety of diseases. Protein A (PrA) is a cell-wall-anchored protein of S. aureus with multiple key roles in colonization and pathogenesis and can be considered as a marker of S. aureus. The development of aptasensors, having an aptamer as a specific biorecognition element, increases selectivity, especially when working with complex matrices. The association with state-of-the-art materials, such as MXenes, can further improve the analytical performance. A competitive aptasensor configuration based on a ferrocene (Fc)-labeled cDNA hybridized (cDNA-Fc S13) on a specific aptamer (APT) for PrA in the presence of MXene nanosheets was designed for the indirect detection of S. aureus. The aptasensor displayed a linear range of 10–125 nM, an LOD of 3.33 nM, and a response time under 40 min. This configuration has been tested in real samples from volunteers diagnosed with S. aureus infections with satisfactory results, enabling the perspective to develop decentralized devices for the rapid detection of bacterial strains. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

17 pages, 4829 KiB  
Article
A Cell-Based Electrochemical Biosensor for the Detection of Infectious Hepatitis A Virus
by Dilmeet Kaur, Malak A. Esseili and Ramaraja P. Ramasamy
Biosensors 2024, 14(12), 576; https://doi.org/10.3390/bios14120576 - 27 Nov 2024
Cited by 2 | Viewed by 1427
Abstract
Hepatitis A virus (HAV), a major cause of acute liver infections, is transmitted through the fecal–oral route and close contact with infected individuals. Current HAV standardized methods rely on the detection of virus antigen or RNA, which do not differentiate between infectious and [...] Read more.
Hepatitis A virus (HAV), a major cause of acute liver infections, is transmitted through the fecal–oral route and close contact with infected individuals. Current HAV standardized methods rely on the detection of virus antigen or RNA, which do not differentiate between infectious and non-infectious HAV. The objective of this study was to develop a prototype cell-based electrochemical biosensor for detection of infectious HAV. A cell culture-adapted HAV strain (HM175/18f) and its permissive cells (FRhK-4), along with gold nanoparticle-modified screen-printed electrodes, were used to develop the biosensor. Electrochemical impedance spectroscopy was used to quantify the electrical impedance signal. Nyquist plots showed successful fabrication of the cell-based biosensor. The optimum period of HAV incubation with the biosensor was 6 h. A significant linear relationship (R2 = 0.98) was found between the signal and a 6-log range of HAV titers, with a limit of detection of ~5 TCID50/mL (tissue culture infectious dose). The biosensor did not detect non-target viruses such as feline calicivirus and human coronavirus 229E. The biosensor was stable for 3 to 7 days at an abusive temperature (37 °C), retaining ~90 to 60% of the original signal, respectively. In conclusion, this prototype cell-based biosensor is capable of rapidly detecting low levels of infectious HAV. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

12 pages, 1275 KiB  
Article
Choline Oxidase-Incorporated ATRP-Based Cerium Nanogels as Nanozymes for Colorimetric Detection of Hydrogen Peroxide and Choline
by Trung Hieu Vu, Byung Jo Yu and Moon Il Kim
Biosensors 2024, 14(12), 563; https://doi.org/10.3390/bios14120563 - 21 Nov 2024
Viewed by 1062
Abstract
Choline is an important molecule in monitoring food safety and infant nutrition. Here, we report Ce nanogels synthesized by atom transfer radical polymerization (ATRP) employing Ce-coordinated acryloyl-lysine polymer brushes (Ce@SiO2 NGs) as highly efficient cascade nanozymes for colorimetric detection of choline. The [...] Read more.
Choline is an important molecule in monitoring food safety and infant nutrition. Here, we report Ce nanogels synthesized by atom transfer radical polymerization (ATRP) employing Ce-coordinated acryloyl-lysine polymer brushes (Ce@SiO2 NGs) as highly efficient cascade nanozymes for colorimetric detection of choline. The synthesized Ce@SiO2 NGs demonstrated remarkable peroxidase-like activity with a porous exterior, which are essential to entrap choline oxidase (COx) to yield COx@Ce@SiO2 NGs and construct a cascade reaction system to detect choline. Immobilized COx catalyzed the oxidation of choline in food samples to produce H2O2, which subsequently induced the oxidation of chromogenic substrate 3,3′,5,5′-tetramethylbenzidine (TMB) to produce blue color signals. This method enabled the selective and sensitive detection of target choline with a satisfactory linear range of 4–400 μM, which is sufficient to analyze foodborne choline. The practical utility of the COx@Ce@SiO2 NG-based assay was successfully validated to determine choline spiked in commercially available milk and infant formula with high accuracy and precision values. This approach provides a simple and affordable method of choline detection and has the potential to lead to more developments in ATRP-based nanozymes for diverse biosensing applications. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

10 pages, 1238 KiB  
Article
Noninvasive Monitoring of Glycemia Level in Diabetic Patients by Wearable Advanced Biosensors
by Elena V. Daboss, Maria A. Komkova, Vita N. Nikitina, Egor A. Andreev, Darya V. Vokhmyanina and Arkady A. Karyakin
Biosensors 2024, 14(10), 486; https://doi.org/10.3390/bios14100486 - 8 Oct 2024
Cited by 2 | Viewed by 2150
Abstract
We report on the possibility of noninvasive diabetes monitoring through continuous analysis of sweat. The prediction of the blood glucose level in diabetic patients is possible on the basis of their sweat glucose content due to the positive correlation discovered. The ratio between [...] Read more.
We report on the possibility of noninvasive diabetes monitoring through continuous analysis of sweat. The prediction of the blood glucose level in diabetic patients is possible on the basis of their sweat glucose content due to the positive correlation discovered. The ratio between the blood glucose and sweat glucose concentrations for a certain diabetic subject is stable within weeks, excluding requirements for frequent blood probing. The glucose variations in sweat display allometric (non-linear) dependence on those in blood, allowing more precise blood glucose estimation. Selective (avoiding false-positive responses) and sensitive (sweat glucose is on average 30–50 times lower) detection is possible with biosensors based on the glucose oxidase enzyme coupled with a Prussian Blue transducer. Reliable glucose detection in just secreted sweat would allow noninvasive monitoring of the glycemia level in diabetic patients. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Graphical abstract

10 pages, 2607 KiB  
Communication
Optical Interferometric Device for Rapid and Specific Detection of Biological Cells
by Sándor Valkai, Dániel Petrovszki, Zsombor Fáskerti, Margaréta Baumgärtner, Brigitta Biczók, Kira Dakos, Kevin Dósa, Berill B. Kirner, Anna E. Kocsis, Krisztina Nagy, István Andó and András Dér
Biosensors 2024, 14(9), 421; https://doi.org/10.3390/bios14090421 - 29 Aug 2024
Viewed by 4673
Abstract
Here, we report a rapid and accurate optical method for detecting cells from liquid samples in a label-free manner. The working principle of the method is based on the interference of parts of a conical laser beam, coming from a single-mode optical fiber [...] Read more.
Here, we report a rapid and accurate optical method for detecting cells from liquid samples in a label-free manner. The working principle of the method is based on the interference of parts of a conical laser beam, coming from a single-mode optical fiber directly, and reflected from a flat glass surface. The glass is functionalized by antibodies against the cells to be detected from the liquid sample. Cells bound to that surface modify the reflected beam, and hence, change the resulting interference pattern, too. By registering and interpreting the variation in the image, the presence of cells from the sample can be detected. As for a demonstration, cell suspensions from a U937 cell line were used in glass chambers functionalized by antibodies (TMG6-5 (mIgG1)) to which the cells specifically bind. The limit of detection (LOD) of the method was also estimated. This proof-of-concept setup offers a cost-effective and easy-to-use way of rapid and specific detection of any type of cells (including pathogens) from suspensions (e.g., body fluids). The possible portability of the device predicts its applicability as a rapid test in clinical diagnostics. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

10 pages, 2573 KiB  
Article
A 3D-Printed Do-It-Yourself ELISA Plate Reader as a Biosensor Tested on TNFα Assay
by Miroslav Pohanka, Ondřej Keresteš and Jitka Žáková
Biosensors 2024, 14(7), 331; https://doi.org/10.3390/bios14070331 - 6 Jul 2024
Cited by 3 | Viewed by 2351
Abstract
Simple analytical devices suitable for the analysis of various biochemical and immunechemical markers are highly desirable and can provide laboratory diagnoses outside standard hospitals. This study focuses on constructing an easily reproducible do-it-yourself ELISA plate reader biosensor device, assembled from generally available and [...] Read more.
Simple analytical devices suitable for the analysis of various biochemical and immunechemical markers are highly desirable and can provide laboratory diagnoses outside standard hospitals. This study focuses on constructing an easily reproducible do-it-yourself ELISA plate reader biosensor device, assembled from generally available and inexpensive parts. The colorimetric biosensor was based on standard 96-well microplates, 3D-printed parts, and a smartphone camera as a detector was utilized here as a tool to replace the ELISA method, and its function was illustrated in the assay of TNFα as a model immunochemical marker. The assay provided a limit of detection of 19 pg/mL when the B channel of the RGB color model was used for calibration. The assay was well correlated with the ELISA method, and no significant matrix effect was observed for standard biological samples or interference of proteins expected in a sample. The results of this study will inform the development of simple analytical devices easily reproducible by 3D printing and found on generally available electronics. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

14 pages, 2533 KiB  
Article
Soft-Template-Based Manufacturing of Gold Nanostructures for Energy and Sensing Applications
by Tushar Kanti Maiti, Wanli Liu, Asghar Niyazi, Adam M. Squires, Sujay Chattpoadhyay and Mirella Di Lorenzo
Biosensors 2024, 14(6), 289; https://doi.org/10.3390/bios14060289 - 3 Jun 2024
Cited by 1 | Viewed by 1438
Abstract
Implantable and wearable bioelectronic systems can enable tailored therapies for the effective management of long-term diseases, thus minimising the risk of associated complications. In this context, glucose fuel cells hold great promise as in- or on-body energy harvesters for ultra-low-power bioelectronics and as [...] Read more.
Implantable and wearable bioelectronic systems can enable tailored therapies for the effective management of long-term diseases, thus minimising the risk of associated complications. In this context, glucose fuel cells hold great promise as in- or on-body energy harvesters for ultra-low-power bioelectronics and as self-powered glucose sensors. We report here the generation of gold nanostructures through a gold electrodeposition method in a soft template for the abiotic electrocatalysis of glucose in glucose fuel cells. Two different types of soft template were used: a lipid cubic phase-based soft template composed of Phytantriol and Brij®-56, and an emulsion-based soft template composed of hexane and sodium dodecyl sulphate (SDS). The resulting gold structures were first characterised by SAXS, SEM and TEM to elucidate their structure, and then their electrocatalytic activity towards glucose was compared in both a three-electrode set-up and in a fuel cell set-up. The Phytantriol/Brij®-56 template led to a nanofeather-like Au structure, while the hexane/SDS template led to a nanocoral-like Au structure. These templated electrodes exhibited similar electrochemical active surface areas (0.446 cm2 with a roughness factor (RF) of 14.2 for Phytantriol/Brij®-56 templated nanostructures and 0.421 cm2 with an RF of 13.4 for hexane/SDS templated nanostructures), and a sensitivity towards glucose of over 7 μA mM−1 cm−2. When tested as the anode of an abiotic glucose fuel cell (in a phosphate-buffered solution with a glucose concentration of 6 mM), a maximum power density of 7 μW cm−2 was reached; however the current density in the case of the fuel cell with the Phytantriol/Brij®-56 templated anode was approximately two times higher, reaching the value of 70 μA cm−2. Overall, this study demonstrates two simple, cost-effective and efficient strategies to manipulate the morphology of gold nanostructures, and thus their catalytic property, paving the way for the successful manufacturing of functional abiotic glucose fuel cells. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

Review

Jump to: Research, Other

35 pages, 11162 KiB  
Review
Hydrogen Peroxide Fuel Cells and Self-Powered Electrochemical Sensors Based on the Principle of a Fuel Cell with Biomimetic and Nanozyme Catalysts
by Yunong Zhang, Yuxin Liu, Andreas Offenhäusser and Yulia Mourzina
Biosensors 2025, 15(2), 124; https://doi.org/10.3390/bios15020124 - 19 Feb 2025
Cited by 1 | Viewed by 926
Abstract
The operating principle of a fuel cell is attracting increasing attention in the development of self-powered electrochemical sensors (SPESs). In this type of sensor, the chemical energy of the analyzed substance is converted into electrical energy in a galvanic cell through spontaneous electrochemical [...] Read more.
The operating principle of a fuel cell is attracting increasing attention in the development of self-powered electrochemical sensors (SPESs). In this type of sensor, the chemical energy of the analyzed substance is converted into electrical energy in a galvanic cell through spontaneous electrochemical reactions, directly generating an analytical signal. Unlike conventional (amperometric, voltammetric, and impedimetric) sensors, no external energy in the form of an applied potential is required for the redox detection reactions to occur. SPESs therefore have several important advantages over conventional electrochemical sensors. They do not require a power supply and modulation system, which saves energy and costs. The devices also offer greater simplicity and are therefore more compatible for applications in wearable sensor devices as well as in vivo and in situ use. Due to the dual redox properties of hydrogen peroxide, it is possible to develop membraneless fuel cells and fuel-cell-based hydrogen peroxide SPESs, in which hydrogen peroxide in the analyzed sample is used as the only source of energy, as both an oxidant and a reductant (fuel). This also suppresses the dependence of the devices on the availability of oxygen. Electrode catalyst materials for different hydrogen peroxide reaction pathways at the cathode and the anode in a one-compartment cell are a key technology for the implementation and characteristics of hydrogen peroxide SPESs. This article provides an overview of the operating principle and designs of H2O2–H2O2 fuel cells and H2O2 fuel-cell-based SPESs, focusing on biomimetic and nanozyme catalysts, and highlights recent innovations and prospects of hydrogen-peroxide-based SPESs for (bio)electrochemical analysis. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

37 pages, 8367 KiB  
Review
Advances in Surface-Enhanced Raman Spectroscopy for Urinary Metabolite Analysis: Exploiting Noble Metal Nanohybrids
by Ningbin Zhao, Peizheng Shi, Zengxian Wang, Zhuang Sun, Kaiqiang Sun, Chen Ye, Li Fu and Cheng-Te Lin
Biosensors 2024, 14(12), 564; https://doi.org/10.3390/bios14120564 - 21 Nov 2024
Cited by 1 | Viewed by 1189
Abstract
This review examines recent advances in surface-enhanced Raman spectroscopy (SERS) for urinary metabolite analysis, focusing on the development and application of noble metal nanohybrids. We explore the diverse range of hybrid materials, including carbon-based, metal–organic-framework (MOF), silicon-based, semiconductor, and polymer-based systems, which have [...] Read more.
This review examines recent advances in surface-enhanced Raman spectroscopy (SERS) for urinary metabolite analysis, focusing on the development and application of noble metal nanohybrids. We explore the diverse range of hybrid materials, including carbon-based, metal–organic-framework (MOF), silicon-based, semiconductor, and polymer-based systems, which have significantly improved SERS performance for detecting key urinary biomarkers. The principles underlying SERS enhancement in these nanohybrids are discussed, elucidating both electromagnetic and chemical enhancement mechanisms. We analyze various fabrication methods that enable precise control over nanostructure morphology, composition, and surface chemistry. The review critically evaluates the analytical performance of different hybrid systems for detecting specific urinary metabolites, considering factors such as sensitivity, selectivity, and stability. We address the analytical challenges associated with SERS-based urinary metabolite analysis, including sample preparation, matrix effects, and data interpretation. Innovative solutions, such as the integration of SERS with microfluidic devices and the application of machine learning algorithms for spectral analysis, are highlighted. The potential of these advanced SERS platforms for point-of-care diagnostics and personalized medicine is discussed, along with future perspectives on wearable SERS sensors and multi-modal analysis techniques. This comprehensive overview provides insights into the current state and future directions of SERS technology for urinary metabolite detection, emphasizing its potential to revolutionize non-invasive health monitoring and disease diagnosis. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

24 pages, 7527 KiB  
Review
CRISPR–Cas Systems Associated with Electrolyte-Gated Graphene-Based Transistors: How They Work and How to Combine Them
by Pierre Guermonprez, Pierre Nioche, Louis Renaud, Nicolas Battaglini, Sébastien Sanaur, Eric Krejci and Benoît Piro
Biosensors 2024, 14(11), 541; https://doi.org/10.3390/bios14110541 - 7 Nov 2024
Cited by 1 | Viewed by 1900
Abstract
In this review, recent advances in the combination of CRISPR–Cas systems with graphene-based electrolyte-gated transistors are discussed in detail. In the first part, the functioning of CRISPR–Cas systems is briefly explained, as well as the most common ways to convert their molecular activity [...] Read more.
In this review, recent advances in the combination of CRISPR–Cas systems with graphene-based electrolyte-gated transistors are discussed in detail. In the first part, the functioning of CRISPR–Cas systems is briefly explained, as well as the most common ways to convert their molecular activity into measurable signals. Other than optical means, conventional electrochemical transducers are also developed. However, it seems that the incorporation of CRISPR/Cas systems into transistor devices could be extremely powerful, as the former provides molecular amplification, while the latter provides electrical amplification; combined, the two could help to advance in terms of sensitivity and compete with conventional PCR assays. Today, organic transistors suffer from poor stability in biological media, whereas graphene materials perform better by being extremely sensitive to their chemical environment and being stable. The need for fast and inexpensive sensors to detect viral RNA arose on the occasion of the COVID-19 crisis, but many other RNA viruses are of interest, such as dengue, hepatitis C, hepatitis E, West Nile fever, Ebola, and polio, for which detection means are needed. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

19 pages, 8697 KiB  
Review
In Situ and Label-Free Quantification of Membrane Protein–Ligand Interactions Using Optical Imaging Techniques: A Review
by Caixin Huang, Jingbo Zhang, Zhaoyang Liu, Jiying Xu, Ying Zhao and Pengfei Zhang
Biosensors 2024, 14(11), 537; https://doi.org/10.3390/bios14110537 - 6 Nov 2024
Cited by 1 | Viewed by 1374
Abstract
Membrane proteins are crucial for various cellular processes and are key targets in pharmacological research. Their interactions with ligands are essential for elucidating cellular mechanisms and advancing drug development. To study these interactions without altering their functional properties in native environments, several advanced [...] Read more.
Membrane proteins are crucial for various cellular processes and are key targets in pharmacological research. Their interactions with ligands are essential for elucidating cellular mechanisms and advancing drug development. To study these interactions without altering their functional properties in native environments, several advanced optical imaging methods have been developed for in situ and label-free quantification. This review focuses on recent optical imaging techniques such as surface plasmon resonance imaging (SPRi), surface plasmon resonance microscopy (SPRM), edge tracking approaches, and surface light scattering microscopy (SLSM). We explore the operational principles, recent advancements, and the scope of application of these methods. Additionally, we address the current challenges and explore the future potential of these innovative optical imaging strategies in deepening our understanding of biomolecular interactions and facilitating the discovery of new therapeutic agents. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

21 pages, 4870 KiB  
Review
Recent Advances in Nanozyme Sensors Based on Metal–Organic Frameworks and Covalent–Organic Frameworks
by Xingliang Cheng, Shuojiang Liu and Yuling Hu
Biosensors 2024, 14(11), 520; https://doi.org/10.3390/bios14110520 - 23 Oct 2024
Cited by 1 | Viewed by 2243
Abstract
Nanozymes are nanomaterials that exhibit enzyme-like catalytic activity, which have drawn increasing attention on account of their unique superiorities including very high robustness, low cost, and ease of modification. Metal–organic frameworks (MOFs) and covalent–organic frameworks (COFs) have emerged as promising candidates for nanozymes [...] Read more.
Nanozymes are nanomaterials that exhibit enzyme-like catalytic activity, which have drawn increasing attention on account of their unique superiorities including very high robustness, low cost, and ease of modification. Metal–organic frameworks (MOFs) and covalent–organic frameworks (COFs) have emerged as promising candidates for nanozymes due to their abundant catalytic activity centers, inherent porosity, and tunable chemical functionalities. In this review, we first compare the enzyme-mimicking activity centers and catalytic mechanisms between MOF and COF nanozymes, and then summarize the recent research on designing and modifying MOF and COF nanozymes with inherent catalytic activity. Moreover, typical examples of sensing applications based on these nanozymes are presented, as well as the translation of enzyme catalytic activity into a visible signal response. At last, a discussion of current challenges is presented, followed by some future prospects to provide guidance for designing nanozyme sensors based on MOFs and COFs for practical applications. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

25 pages, 5952 KiB  
Review
The Evolution of Illicit-Drug Detection: From Conventional Approaches to Cutting-Edge Immunosensors—A Comprehensive Review
by Nigar Anzar, Shariq Suleman, Yashda Singh, Supriya Kumari, Suhel Parvez, Roberto Pilloton and Jagriti Narang
Biosensors 2024, 14(10), 477; https://doi.org/10.3390/bios14100477 - 3 Oct 2024
Cited by 2 | Viewed by 2318
Abstract
The increasing use of illicit drugs has become a major global concern. Illicit drugs interact with the brain and the body altering an individual’s mood and behavior. As the substance-of-abuse (SOA) crisis continues to spread across the world, in order to reduce trafficking [...] Read more.
The increasing use of illicit drugs has become a major global concern. Illicit drugs interact with the brain and the body altering an individual’s mood and behavior. As the substance-of-abuse (SOA) crisis continues to spread across the world, in order to reduce trafficking and unlawful activity, it is important to use point-of-care devices like biosensors. Currently, there are certain conventional detection methods, which include gas chromatography (GC), mass spectrometry (MS), surface ionization, surface-enhanced Raman spectroscopy (SERS), surface plasmon resonance (SPR), electrochemiluminescence (ECL), high-performance liquid chromatography (HPLC), etc., for the detection of abused drugs. These methods have the advantage of high accuracy and sensitivity but are generally laborious, expensive, and require trained operators, along with high sample requirements, and they are not suitable for on-site drug detection scenarios. As a result, there is an urgent need for point-of-care technologies for a variety of drugs that can replace conventional techniques, such as a biosensor, specifically an immunosensor. An immunosensor is an analytical device that integrates an antibody-based recognition element with a transducer to detect specific molecules (antigens). In an immunosensor, the highly selective antigen–antibody interaction is used to identify and quantify the target analyte. The binding event between the antibody and antigen is converted by the transducer into a measurable signal, such as electrical, optical, or electrochemical, which corresponds to the presence and concentration of the analyte in the sample. This paper provides a comprehensive overview of various illicit drugs, the conventional methods employed for their detection, and the advantages of immunosensors over conventional techniques. It highlights the critical need for on-site detection and explores emerging point-of-care testing methods. The paper also outlines future research goals in this field, emphasizing the potential of advanced technologies to enhance the accuracy, efficiency, and convenience of drug detection. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

Other

Jump to: Research, Review

9 pages, 1078 KiB  
Brief Report
Paralytic Shellfish Toxin Extraction from Bivalve Meat for Analysis Using Potentiometric Chemical Sensors
by Ana Filipa R. Cerqueira, Catarina Moreirinha, Mariana Raposo, Maria Teresa S. R. Gomes, Sara T. Costa, Maria João Botelho and Alisa Rudnitskaya
Biosensors 2024, 14(10), 487; https://doi.org/10.3390/bios14100487 - 8 Oct 2024
Viewed by 1199
Abstract
A simple and reliable methodology for the detection of paralytic shellfish toxins (PSTs) in bivalve tissues using potentiometric chemical sensors was developed. Five methods of PST extraction from mussel and oyster tissues were evaluated, including the AOAC-recommended method, which served as the reference. [...] Read more.
A simple and reliable methodology for the detection of paralytic shellfish toxins (PSTs) in bivalve tissues using potentiometric chemical sensors was developed. Five methods of PST extraction from mussel and oyster tissues were evaluated, including the AOAC-recommended method, which served as the reference. The main objective was to minimize the matrix effect of the extracts on the sensors’ responses and ensure efficient toxin recovery. Extraction procedures using acetic acid with heating and water yielded the highest responses from the potentiometric chemical sensors to PSTs. The highest recovery of PSTs from bivalve tissues was achieved with extraction using acetic acid and heating. Further extract purification, which is indispensable for liquid chromatography with fluorometric detection (LC-FLD) analysis, was found to be unnecessary for analysis with chemical sensors. While water extraction can also be used as a rapid and simple PST extraction method, the lower recoveries should be considered when interpreting the results. Further research is needed to identify the compounds remaining in the extracts that cause a decrease in sensor responses and to develop procedures for their elimination. Full article
(This article belongs to the Special Issue Feature Paper in Biosensor and Bioelectronic Devices 2024)
Show Figures

Figure 1

Back to TopTop